The gene expression of SPP1 and APOE, two gene products associated with AD pathology, were both uniquely and significantly reduced by exposure to metformin, a drug that penetrates the blood-brain barrier, at pharmacologically relevant drug concentrations. The gene discussed is SPP1; the disease is Alzheimer disease.